US Cancer Costs Double in Nearly 20 Years
Study says US cancer costs almost double in 20 years _ but not because of pricey treatments Cancer – Health – Conditions and Diseases – Organizations – Gastrointestinal
Read more on ABC News
US Cancer Costs Double in Nearly 20 Years
America’s First Therapeutic Cancer Vaccine
America’s First Therapeutic Cancer Vaccine
Last Thursday the Food and Drug Administration approved Provenge for the treatment of advanced prostate cancer. Provenge is the first therapeutic vaccine to be approved in the U.S. for cancer treatment, ushering in what may be a new era in immune-based cancer treatments. Approval marks the successful conclusion of a 20-year odyssey with some remarkable twists and turns. My part of the story …
Read more on The Atlantic
Related posts
Mutation quadruples repeat breast cancer risk
Mutation quadruples repeat breast cancer risk
WASHINGTON, April 5 (Reuters) – Younger breast cancer patients who have a mutation in the well-known BRCA1 or BRCA2 genes are four times as likely to get cancer in the other breast as most patients, researchers reported on Monday.
Read more on AsiaOne